Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative

Pharmaceutical Research

Volumn 25, Issue 1, 2008, Pages 48-54

  Alani, Adam W G ^a   Robinson, Joseph R ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Caco 2 cell line; Cromolyn sodium; GI tract drug absorption; Lipophilicity; Membrane fluidity; SNAC

Indexed keywords

AMINO ACID DERIVATIVE; CROMOGLYCATE DISODIUM; HYDROGEN; SODIUM N [8 (2 HYDROXYBENZOYL)AMINO]CAPRYLATE; UNCLASSIFIED DRUG;

ANISOTROPY; ARTICLE; CELL MEMBRANE FLUIDITY; CELL STRAIN CACO 2; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; FLUIDIZATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEN BOND; HYDROPHOBICITY; LIPOPHILICITY; PRIORITY JOURNAL; STEADY STATE;

ADMINISTRATION, ORAL; ALGORITHMS; ANTI-ASTHMATIC AGENTS; CACO-2 CELLS; CAPRYLATES; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROMOLYN SODIUM; EXCIPIENTS; FLUORESCENCE POLARIZATION; HUMANS; HYDROGEN BONDING; INTESTINAL ABSORPTION; MEMBRANE FLUIDITY;

EID: 38049183272     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9438-6     Document Type: Article

References (32)

1. S. Budavari, M. J. O'Neil, A. Smith, and P. E. Heckelman. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals (Merck Index), MERCK & CO., Inc., Rahway, NJ, 1989.
2. H. S. White. Histamine and antihistamine drugs. In Remington (ed.), The Science and Practice of Pharmacy, Williams & Wilkins, Philadelphia, 2000, pp. 1464-1476.
3. T. Mori, K. Nishimura, S. Tamaki, S. Nakamura, H. Tsuda, and N. Kakeya. Pro-drug for the oral delivery of disodium cromoglycate. Chem. Pharm. Bull. 36:338-344 (1988).
4. PDR®. Physician's Desk Reference, Thomson PDR, 1992.
5. A. Yoshimi, H. Hashizume, S. Tamaki, H. Tsuda, F. Fukata, K. Nishimura, and N. Yata. Importance of hydrolysis amino acid moiety in water-soluble prodrug of disodium cromoglycate for increased oral bioavailibility. J. Pharmacobio-Dyn. 15:339-345 (1992).
6. A. Leone-Bay, H. Leipold, D. Sarubbi, B. Variano, T. Rivera, and R. A. Baughman. Oral delivery of sodium cromolyn: preliminary studies in vivo and in vitro. Pharm. Res. 13:222-226 (1996).
7. Emisphere Technology. Emisphere's oral cromolyn sodium program, http://www.emisphere.com/pc_ocs.asp.
8. M. Goldbege. Oral macromolecule delivery: review of the large and expanding clinical database. Winter symposium & 11th International symposium on recent advanced drug delivery systems, Salt Lake city, Utah, 2003.
9. S.-J. Wu. Mechanistic studies on the Enhanced Mucosal Transport of Human Growth Hormone by Certain Amino Acid Derivatives, School of Pharmacy, University of Wisconsin, Madison, 1999.
10. TM technology. Drug Deliv. Technol. 3:53-62 (2003).
11. D. Brayden, E. Creed, A. O'Connell, H. Leiopold, R. Agarwal, and A. Leone-Bay. Heparin absorption across the intestine: Effect of Sodium N-[8-(2-Hydroxybenzoyl)amino]Caprylate in rat In situ Instillations and in Caco-2 monolayers. Pharm. Res. 14:1772-1778 (1997).
12. B. Li. Non-covalent Carrier Enhanced Protein Absorption-cellular and Subcellular Mechanistic Studies, School of Pharmacy, University of Wisconsin, Madison, 2001.
13. S.-J. Wu and J. R. Robinson. Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone. Pharm. Res. V16:1266-1272 (1999).
14. X. Ding, P. Rath, R. Angelo, T. Stringfellow, E. Flanders, S. Dinh, I. Gomez-Orellana, and J. R. Robinson. Oral absorption enhancement of cromolyn sodium through noncovalent complexation. Pharm. Res. 21:2196-2206 (2004).
15. J. C. Dearden and G. M. Bresnen. The measurement of partition coefficients. Quant. Struct.-Act. Relatsh. 7:133-144 (1988).
16. B. D. Rege, J. P. Y. Kao, and J. E. Polli. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur. J. Pharm. Sci. 16:237-246 (2002).
17. F. Giraud, M. Claret, K. R. Bruckdorfer, and B. Chailley. The effects of membrane lipid order and cholesterol on the internal and external cationic sites of the Na+-K+ pump in erythrocytes. Biochim. Biophys. Acta Biomembr. 647:249-258 (1981).
18. X. Ding. Oral Absorption Enhancement of Cromolyn Sodium Through Non-covalent Complexation, Pharmaceutical Sciences, University of Wisconsin-Madison, Madison, 2004, pp. 153.
19. A. Leone-Bay, D. R. Paton, J. Freeman, C. Lercara, D. O'Toole, D. Gschneidner, E. Wang, E. Harris, C. Rosado, T. Rivera, A. DeVincent, M. Tai, F. Mercogliano, R. Agarwal, H. Leiopold, and R. A. Baughman. Synthetic and evaluation of compounds that facilitate the gastrointestinal absorption of heparin. J. Med. Chem. 41:1163-1171 (1998).
20. A. Leone-Bay, C. McInnes, N. Wang, F. DeMorin, D. Achan, C. Lercara, D. Sarubbi, S. Hass, J. Press, E. Barantseich, B. O'Broin, S. Milstein, and D. Paton. Microsphere formation in a series of derivatized a-amino acids: Properties, molecular modeling, and oral delivery of Salmon Calcitonin. J. Med. Chem. 38:4257-4262 (1995).
21. A. Leone-Bay, N. Santiago, D. Achan, K. Chaudhary, F. DeMorin, L. Falzarano, S. Hass, S. Kalbag, D. Kaplan, H. Leiopold, C. Lercara, D. O'Toole, T.Rivera, C. Rosado, S. D, E. Vauocolo, N. Wang, S. Milstein, and R. A. Baughman. N-acelated-a-amino acids as novel oral delivery agents for proteins. J. Med. Chem. 38:4263-4269 (1995).
22. J. L. Madara. Regulation of the movement of solutes across tight junctions. Annu. Rev. Physiol. 60:143-159 (1998).
23. A. L. Daugherty and R. J. Mrsny. Transcellular uptake mechanisms of the intestinal epithelial barrier part one. Pharm. Sci. Technol. Today 2:144-151 (1999).
24. E. C. Swenson and W. J. Curatolo. Intestinal permeability enhancement for proteins, peptides and other polar drugs: Mechanisms and potential toxicity. Adv. Drug Deliv. Rev. 8:39-92 (1992).
25. E. S. Swenson, W. B. Milisen, and W. Curatolo. Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm. Res. 11:1132-1142 (1994).
26. W. L. Hayton, D. E. Gutman, and G. Levy. Effect of complex formation on drug absorption XI: Complexation of prednisone and prednisolone with dialkylpropionamide and its effect on prednisone transfer through artificial lipoid barrier. J. Pharm. Sci. 61:356-361 (1972).
27. W. L. Hayton and G. Levy. Effect of complex formation on drug absorption XII: Enhancement of intestinal absorption of prednisone and prednisolone by dialkylpropionamide in rats. J. Pharm. Sci. 61:362-366 (1972).
28. W. L. Hayton and G. Levy. Effect of complex formation on drug absorption XV: Structural requirement for enhancement of intestinal absorption of steroids by N,N-Di-n-propylpropionamide. J. Pharm. Sci. 61:649-651 (1972).
29. W. L. Hayton and G. Levy. Effect of complex formation on drug absorption XIII: Effect of constant concentration of N,N-Di-n-propylpropionamide on prednisolone absorption from rate small intestine. J. Pharm. Sci. 61:367-371 (1972).
30. W. L. Hayton, G. Levy, and C. Regardh. Effect of complex formation on drug absorption XIV: effect of N,N-Di-n-propylpropionamide on intestinal absorption of certain nonsteroid drugs in the rat. J. Pharm. Sci. 61:473-474 (1972).
31. A. G. Alani and J. R. Robinson. Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative, Thirteenth International Symposium on Recent Advances in Drug Delivery Systems "Overcoming long-standing barriers", Salt Lake City, UT, 2007.
32. A. G. Alani and J. R. Robinson. Mechanistic Understanding of Oral Drug Absorption Enhancement of Cromolyn Sodium by an Amino Acid Derivative, School of Pharmacy, University of Wisconsin, Madison, 2007, p. 178.